Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor ungefähr 2 Monaten |
| Titel | Datum |
|---|---|
| SUNESIS PHARMACEUTICALS INC - 8-K, Current Report | vor 29 Tagen |
| SUNESIS PHARMACEUTICALS INC - S-4, Registration of securities, business combinations | vor 29 Tagen |
| Sunesis rises 1.9% after Viracta sees registration trial in H1 for lymphoma regimen | vor ungefähr einem Monat |
| Sunesis Pharmaceuticals News: 7 Things for SNSS Stock Investors to Know About the Viracta Deal | vor ungefähr 2 Monaten |
| Sunesis Jumps on Merger Deal with Viracta Therapeutics | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |